The FDA has approved the combination of lurbinectedin (Zepzelca) and the immunotherapy atezolizumab (Tecentriq) for first-line maintenance treatment in patients with extensive-stage small cell lung ...
Natco Pharma has secured yet another favourable ruling against a drug innovator, allowing it to sell a generic version of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback